n ras Search Results


92
Cytoskeleton Inc recombinant protein

Recombinant Protein, supplied by Cytoskeleton Inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/n+ras/pmc07909951-46-1-6?v=Cytoskeleton+Inc
Average 92 stars, based on 1 article reviews
recombinant protein - by Bioz Stars, 2026-08
92/100 stars
  Buy from Supplier

91
Santa Cruz Biotechnology n ras

N Ras, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/n+ras/10__1128_slash_jvi__79__14__8742___8749__2005-84-12-13?v=Santa+Cruz+Biotechnology
Average 91 stars, based on 1 article reviews
n ras - by Bioz Stars, 2026-08
91/100 stars
  Buy from Supplier

95
Santa Cruz Biotechnology nras

Nras, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/n+ras/pmc07843419__41388_2020_1567_MOESM1_ESM-6-8-17?v=Santa+Cruz+Biotechnology
Average 95 stars, based on 1 article reviews
nras - by Bioz Stars, 2026-08
95/100 stars
  Buy from Supplier

92
Addgene inc pbabe nras 61k construct

Pbabe Nras 61k Construct, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/n+ras/us10815484-577-7-16?v=Addgene+inc
Average 92 stars, based on 1 article reviews
pbabe nras 61k construct - by Bioz Stars, 2026-08
92/100 stars
  Buy from Supplier

93
Proteintech anti nras

Anti Nras, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/n+ras/pmc08458072__gutjnl___2020___322779supp002-69-10-12?v=Proteintech
Average 93 stars, based on 1 article reviews
anti nras - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

93
Proteintech csde1 affinity df12920 wb

Csde1 Affinity Df12920 Wb, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/n+ras/pmc08983694__41420_2022_992_MOESM1_ESM-25-15-7?v=Proteintech
Average 93 stars, based on 1 article reviews
csde1 affinity df12920 wb - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

90
Addgene inc pcgn nras 12d plasmid

Pcgn Nras 12d Plasmid, supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/n+ras/pmc05377799-978-2-6?v=Addgene+inc
Average 90 stars, based on 1 article reviews
pcgn nras 12d plasmid - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Proteintech c2c12 cells expressing gfp2 k ras
(A) Confocal images of <t>C2C12</t> cells grown in high serum for 72 h and immunolabelled for Pax7 in the nucleus and ciliary marker Arl13B. Phalloidin staining visualizes cell outlines. Scale bar = 20 µm. (B) Quantification of ciliation using data as in (A), N = 3 independent biological repeats with a total of n = 800 cells. Means ± SD are plotted. Statistical analysis was done with the unpaired t-test. ( C-F ) Modelled (curves) and measured (points) of the population evolution of MuSC, TAC and differentiated C2C12 cells (Diff) after serum switching at day 0 to trigger differentiation. Experimental samples were treated at day -1 with non-targeting siRNA (siCTRL, C), siRNA targeting KRAS4A/4B (si-pan KRAS, D), NRAS (E) or HRAS (F). Plots to the right show predicted percentage of ciliated cells over time with the line indicating day 3 in differentiating low serum. (G) Confocal imaging-based quantification of ciliation of C2C12 transfected with the indicated siRNA (100 nM) and grown in low serum for 72 h. N = 3, n > 500. Means ± SD are plotted. Statistical analysis was done with one-way ANOVA and the Dunnett’s T3 multiple comparisons test. (H) Flow cytometric quantification of MyHC terminal differentiation marker expression in C2C12 treated as in (G), N = 3. Means ± SD are plotted. Statistical analysis was done with one-way ANOVA and Dunnett’s T3 multiple comparisons test.
C2c12 Cells Expressing Gfp2 K Ras, supplied by Proteintech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/n+ras/bio_rxiv__64898__2026__03__05__709789-273-6-20?v=Proteintech
Average 90 stars, based on 1 article reviews
c2c12 cells expressing gfp2 k ras - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
OriGene n ras plasmid
(A) Confocal images of <t>C2C12</t> cells grown in high serum for 72 h and immunolabelled for Pax7 in the nucleus and ciliary marker Arl13B. Phalloidin staining visualizes cell outlines. Scale bar = 20 µm. (B) Quantification of ciliation using data as in (A), N = 3 independent biological repeats with a total of n = 800 cells. Means ± SD are plotted. Statistical analysis was done with the unpaired t-test. ( C-F ) Modelled (curves) and measured (points) of the population evolution of MuSC, TAC and differentiated C2C12 cells (Diff) after serum switching at day 0 to trigger differentiation. Experimental samples were treated at day -1 with non-targeting siRNA (siCTRL, C), siRNA targeting KRAS4A/4B (si-pan KRAS, D), NRAS (E) or HRAS (F). Plots to the right show predicted percentage of ciliated cells over time with the line indicating day 3 in differentiating low serum. (G) Confocal imaging-based quantification of ciliation of C2C12 transfected with the indicated siRNA (100 nM) and grown in low serum for 72 h. N = 3, n > 500. Means ± SD are plotted. Statistical analysis was done with one-way ANOVA and the Dunnett’s T3 multiple comparisons test. (H) Flow cytometric quantification of MyHC terminal differentiation marker expression in C2C12 treated as in (G), N = 3. Means ± SD are plotted. Statistical analysis was done with one-way ANOVA and Dunnett’s T3 multiple comparisons test.
N Ras Plasmid, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/n+ras/pm24861879-79-40-42?v=OriGene
Average 90 stars, based on 1 article reviews
n ras plasmid - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

92
Addgene inc ha tagged nras
(A) Confocal images of <t>C2C12</t> cells grown in high serum for 72 h and immunolabelled for Pax7 in the nucleus and ciliary marker Arl13B. Phalloidin staining visualizes cell outlines. Scale bar = 20 µm. (B) Quantification of ciliation using data as in (A), N = 3 independent biological repeats with a total of n = 800 cells. Means ± SD are plotted. Statistical analysis was done with the unpaired t-test. ( C-F ) Modelled (curves) and measured (points) of the population evolution of MuSC, TAC and differentiated C2C12 cells (Diff) after serum switching at day 0 to trigger differentiation. Experimental samples were treated at day -1 with non-targeting siRNA (siCTRL, C), siRNA targeting KRAS4A/4B (si-pan KRAS, D), NRAS (E) or HRAS (F). Plots to the right show predicted percentage of ciliated cells over time with the line indicating day 3 in differentiating low serum. (G) Confocal imaging-based quantification of ciliation of C2C12 transfected with the indicated siRNA (100 nM) and grown in low serum for 72 h. N = 3, n > 500. Means ± SD are plotted. Statistical analysis was done with one-way ANOVA and the Dunnett’s T3 multiple comparisons test. (H) Flow cytometric quantification of MyHC terminal differentiation marker expression in C2C12 treated as in (G), N = 3. Means ± SD are plotted. Statistical analysis was done with one-way ANOVA and Dunnett’s T3 multiple comparisons test.
Ha Tagged Nras, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/n+ras/pm41597217-69-11-17?v=Addgene+inc
Average 92 stars, based on 1 article reviews
ha tagged nras - by Bioz Stars, 2026-08
92/100 stars
  Buy from Supplier

90
OriGene anti ay 2024 acris ap30656pu-n
(A) Confocal images of <t>C2C12</t> cells grown in high serum for 72 h and immunolabelled for Pax7 in the nucleus and ciliary marker Arl13B. Phalloidin staining visualizes cell outlines. Scale bar = 20 µm. (B) Quantification of ciliation using data as in (A), N = 3 independent biological repeats with a total of n = 800 cells. Means ± SD are plotted. Statistical analysis was done with the unpaired t-test. ( C-F ) Modelled (curves) and measured (points) of the population evolution of MuSC, TAC and differentiated C2C12 cells (Diff) after serum switching at day 0 to trigger differentiation. Experimental samples were treated at day -1 with non-targeting siRNA (siCTRL, C), siRNA targeting KRAS4A/4B (si-pan KRAS, D), NRAS (E) or HRAS (F). Plots to the right show predicted percentage of ciliated cells over time with the line indicating day 3 in differentiating low serum. (G) Confocal imaging-based quantification of ciliation of C2C12 transfected with the indicated siRNA (100 nM) and grown in low serum for 72 h. N = 3, n > 500. Means ± SD are plotted. Statistical analysis was done with one-way ANOVA and the Dunnett’s T3 multiple comparisons test. (H) Flow cytometric quantification of MyHC terminal differentiation marker expression in C2C12 treated as in (G), N = 3. Means ± SD are plotted. Statistical analysis was done with one-way ANOVA and Dunnett’s T3 multiple comparisons test.
Anti Ay 2024 Acris Ap30656pu N, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/n+ras/10__1158_slash_1541___7786__mcr___16___0301-78-72-74?v=OriGene
Average 90 stars, based on 1 article reviews
anti ay 2024 acris ap30656pu-n - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
OriGene pcmv6
(A) Confocal images of <t>C2C12</t> cells grown in high serum for 72 h and immunolabelled for Pax7 in the nucleus and ciliary marker Arl13B. Phalloidin staining visualizes cell outlines. Scale bar = 20 µm. (B) Quantification of ciliation using data as in (A), N = 3 independent biological repeats with a total of n = 800 cells. Means ± SD are plotted. Statistical analysis was done with the unpaired t-test. ( C-F ) Modelled (curves) and measured (points) of the population evolution of MuSC, TAC and differentiated C2C12 cells (Diff) after serum switching at day 0 to trigger differentiation. Experimental samples were treated at day -1 with non-targeting siRNA (siCTRL, C), siRNA targeting KRAS4A/4B (si-pan KRAS, D), NRAS (E) or HRAS (F). Plots to the right show predicted percentage of ciliated cells over time with the line indicating day 3 in differentiating low serum. (G) Confocal imaging-based quantification of ciliation of C2C12 transfected with the indicated siRNA (100 nM) and grown in low serum for 72 h. N = 3, n > 500. Means ± SD are plotted. Statistical analysis was done with one-way ANOVA and the Dunnett’s T3 multiple comparisons test. (H) Flow cytometric quantification of MyHC terminal differentiation marker expression in C2C12 treated as in (G), N = 3. Means ± SD are plotted. Statistical analysis was done with one-way ANOVA and Dunnett’s T3 multiple comparisons test.
Pcmv6, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/n+ras/pmc04165420-124-39-41?v=OriGene
Average 90 stars, based on 1 article reviews
pcmv6 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


Journal: eLife

Article Title: Complex structures of Rsu1 and PINCH1 reveal a regulatory mechanism of the ILK/PINCH/Parvin complex for F-actin dynamics

doi: 10.7554/eLife.64395

Figure Lengend Snippet:

Article Snippet: Peptide, recombinant protein , actin , Cytoskeleton, Inc , Cat. # AKL99 , Rabbit Skeletal Muscle.

Techniques: Recombinant, Expressing, Transfection, Staining, Western Blot, Software

(A) Confocal images of C2C12 cells grown in high serum for 72 h and immunolabelled for Pax7 in the nucleus and ciliary marker Arl13B. Phalloidin staining visualizes cell outlines. Scale bar = 20 µm. (B) Quantification of ciliation using data as in (A), N = 3 independent biological repeats with a total of n = 800 cells. Means ± SD are plotted. Statistical analysis was done with the unpaired t-test. ( C-F ) Modelled (curves) and measured (points) of the population evolution of MuSC, TAC and differentiated C2C12 cells (Diff) after serum switching at day 0 to trigger differentiation. Experimental samples were treated at day -1 with non-targeting siRNA (siCTRL, C), siRNA targeting KRAS4A/4B (si-pan KRAS, D), NRAS (E) or HRAS (F). Plots to the right show predicted percentage of ciliated cells over time with the line indicating day 3 in differentiating low serum. (G) Confocal imaging-based quantification of ciliation of C2C12 transfected with the indicated siRNA (100 nM) and grown in low serum for 72 h. N = 3, n > 500. Means ± SD are plotted. Statistical analysis was done with one-way ANOVA and the Dunnett’s T3 multiple comparisons test. (H) Flow cytometric quantification of MyHC terminal differentiation marker expression in C2C12 treated as in (G), N = 3. Means ± SD are plotted. Statistical analysis was done with one-way ANOVA and Dunnett’s T3 multiple comparisons test.

Journal: bioRxiv

Article Title: K-Ras controls asymmetric cell divisions from the primary cilium

doi: 10.64898/2026.03.05.709789

Figure Lengend Snippet: (A) Confocal images of C2C12 cells grown in high serum for 72 h and immunolabelled for Pax7 in the nucleus and ciliary marker Arl13B. Phalloidin staining visualizes cell outlines. Scale bar = 20 µm. (B) Quantification of ciliation using data as in (A), N = 3 independent biological repeats with a total of n = 800 cells. Means ± SD are plotted. Statistical analysis was done with the unpaired t-test. ( C-F ) Modelled (curves) and measured (points) of the population evolution of MuSC, TAC and differentiated C2C12 cells (Diff) after serum switching at day 0 to trigger differentiation. Experimental samples were treated at day -1 with non-targeting siRNA (siCTRL, C), siRNA targeting KRAS4A/4B (si-pan KRAS, D), NRAS (E) or HRAS (F). Plots to the right show predicted percentage of ciliated cells over time with the line indicating day 3 in differentiating low serum. (G) Confocal imaging-based quantification of ciliation of C2C12 transfected with the indicated siRNA (100 nM) and grown in low serum for 72 h. N = 3, n > 500. Means ± SD are plotted. Statistical analysis was done with one-way ANOVA and the Dunnett’s T3 multiple comparisons test. (H) Flow cytometric quantification of MyHC terminal differentiation marker expression in C2C12 treated as in (G), N = 3. Means ± SD are plotted. Statistical analysis was done with one-way ANOVA and Dunnett’s T3 multiple comparisons test.

Article Snippet: To visualize K-Ras with STED microscopy, C2C12 cells expressing GFP2-K-Ras were fixed with 4 % (w/v) paraformaldehyde and immunolabelled with ChromoTek GFP-booster ATTO647N.

Techniques: Marker, Staining, Imaging, Transfection, Expressing

( A-C ) Confocal images of C2C12 cells grown in high serum for 48 h after transfection with GFP2-K-Ras (A, n = 73), GFP2-N-Ras (B, n = 48) or GFP2-H-Ras (C, n = 47) and immunolabeled for ciliary marker Arl13B (arrow). Bottom , images show orthogonal views. Scale bar = 10 µm. (D) Quantification of Ras signal in the primary cilium (PC) as compared to the plasma membrane (PM) using data as in (A-C), N = 3. Means ± SD are plotted. Statistical comparison was done against K-Ras with the Kruskal-Wallis test and Dunn’s post hoc test. (E) Confocal images of C2C12 cells treated with PDE6D-targeting siRNA (100 nM), transfected with GFP2-K-Ras and cultured thereafter for 48 h in high serum. Scale bar = 10 µm. (F) Quantification of K-Ras signal in the primary cilium (PC) as compared to the plasma membrane (PM) using data as in (E), N = 3; siCTRL, n = 30; si PDE6D , n = 30. Means ± SD are plotted. Statistical analysis was done with the Mann-Whitney test. (G) Confocal images of C2C12-mEos3.2-KRAS knock-in cells cultured in high serum for 24 h directly after FACS-sorting and immunolabelled for ciliary marker Arl13B and centriolar marker γ-tubulin. Scale bar = 10 µm.

Journal: bioRxiv

Article Title: K-Ras controls asymmetric cell divisions from the primary cilium

doi: 10.64898/2026.03.05.709789

Figure Lengend Snippet: ( A-C ) Confocal images of C2C12 cells grown in high serum for 48 h after transfection with GFP2-K-Ras (A, n = 73), GFP2-N-Ras (B, n = 48) or GFP2-H-Ras (C, n = 47) and immunolabeled for ciliary marker Arl13B (arrow). Bottom , images show orthogonal views. Scale bar = 10 µm. (D) Quantification of Ras signal in the primary cilium (PC) as compared to the plasma membrane (PM) using data as in (A-C), N = 3. Means ± SD are plotted. Statistical comparison was done against K-Ras with the Kruskal-Wallis test and Dunn’s post hoc test. (E) Confocal images of C2C12 cells treated with PDE6D-targeting siRNA (100 nM), transfected with GFP2-K-Ras and cultured thereafter for 48 h in high serum. Scale bar = 10 µm. (F) Quantification of K-Ras signal in the primary cilium (PC) as compared to the plasma membrane (PM) using data as in (E), N = 3; siCTRL, n = 30; si PDE6D , n = 30. Means ± SD are plotted. Statistical analysis was done with the Mann-Whitney test. (G) Confocal images of C2C12-mEos3.2-KRAS knock-in cells cultured in high serum for 24 h directly after FACS-sorting and immunolabelled for ciliary marker Arl13B and centriolar marker γ-tubulin. Scale bar = 10 µm.

Article Snippet: To visualize K-Ras with STED microscopy, C2C12 cells expressing GFP2-K-Ras were fixed with 4 % (w/v) paraformaldehyde and immunolabelled with ChromoTek GFP-booster ATTO647N.

Techniques: Transfection, Immunolabeling, Marker, Clinical Proteomics, Membrane, Comparison, Cell Culture, MANN-WHITNEY, Knock-In

(A) Confocal images of C2C12 cells grown in high serum for 24 h after transfection with mEGFP-K-Ras. Images were acquired before (-1 s) and after (1 – 4 s) photobleaching at 0 s. Images represent the 10 µm × 10 µm photobleached region. FRAP was monitored at the ciliary tip (arrowhead) and wider base (arrow). Scale bar = 4 µm. (B) Recovery curves for tip and base using data as in (A). Mean ± SEM of fluorescence intensities from all cells per time point, N = 3, n = 23 per condition. ( C , D ) Analysis of individual FRAP curves summarized in (B) yielded diffusion coefficient (C; N = 3, n = 15) and mobile fraction (D; N = 3, n = 23) at ciliary tip and base. Means ± SD are plotted. Statistical analysis was done with the Mann-Whitney test. ( E, F ) STED images of C2C12 cells grown in high serum for 48 h after transfection with GFP2-K-Ras and immunolabeled for GFP using an ATTO647N-conjugated nanobody and ciliary membrane marker Arl13B or centriolar marker γ-tubulin. Position of the cilium (arrowhead) relative to the centrioles (arrow) is indicated. Scale bar = 2 µm. ( G, H ) Confocal images of C2C12 cells grown in high serum for 48 h. Cells were not transfected with K-Ras constructs, but with GFP2-B-Raf (G) and immunolabelled for acetylated α-tubulin marking the cilium (G; N = 3, n = 50) or immunolabelled for endogenous phospho-S217/S221-MEK1/2 and acetylated α-tubulin to mark the cilium (H; N = 3, n = 50). Scale bar = 2 µm.

Journal: bioRxiv

Article Title: K-Ras controls asymmetric cell divisions from the primary cilium

doi: 10.64898/2026.03.05.709789

Figure Lengend Snippet: (A) Confocal images of C2C12 cells grown in high serum for 24 h after transfection with mEGFP-K-Ras. Images were acquired before (-1 s) and after (1 – 4 s) photobleaching at 0 s. Images represent the 10 µm × 10 µm photobleached region. FRAP was monitored at the ciliary tip (arrowhead) and wider base (arrow). Scale bar = 4 µm. (B) Recovery curves for tip and base using data as in (A). Mean ± SEM of fluorescence intensities from all cells per time point, N = 3, n = 23 per condition. ( C , D ) Analysis of individual FRAP curves summarized in (B) yielded diffusion coefficient (C; N = 3, n = 15) and mobile fraction (D; N = 3, n = 23) at ciliary tip and base. Means ± SD are plotted. Statistical analysis was done with the Mann-Whitney test. ( E, F ) STED images of C2C12 cells grown in high serum for 48 h after transfection with GFP2-K-Ras and immunolabeled for GFP using an ATTO647N-conjugated nanobody and ciliary membrane marker Arl13B or centriolar marker γ-tubulin. Position of the cilium (arrowhead) relative to the centrioles (arrow) is indicated. Scale bar = 2 µm. ( G, H ) Confocal images of C2C12 cells grown in high serum for 48 h. Cells were not transfected with K-Ras constructs, but with GFP2-B-Raf (G) and immunolabelled for acetylated α-tubulin marking the cilium (G; N = 3, n = 50) or immunolabelled for endogenous phospho-S217/S221-MEK1/2 and acetylated α-tubulin to mark the cilium (H; N = 3, n = 50). Scale bar = 2 µm.

Article Snippet: To visualize K-Ras with STED microscopy, C2C12 cells expressing GFP2-K-Ras were fixed with 4 % (w/v) paraformaldehyde and immunolabelled with ChromoTek GFP-booster ATTO647N.

Techniques: Transfection, Fluorescence, Diffusion-based Assay, MANN-WHITNEY, Immunolabeling, Membrane, Marker, Construct

(A) BRET titration curve of Rluc8-PDE6D and GFP2-K-Ras-SI as compared to GFP2-K-Ras expressed in HEK cells, N = 3. Means ± SD are plotted. Statistical analysis was performed with the extra sum-of-squares F-test. ( B, C ) Confocal images of C2C12 cells grown in low serum for 72 h after transfection with mEGFP-K-Ras (top) or mEGFP-K-Ras-SI (bottom) and immunolabelled for ciliary markers (arrows) Arl13B (B) or acetylated α-tubulin (C). The mCherry-PDE6D construct was co-expressed at 1:1 DNA ratio with K-Ras variant constructs (C). Scale = 10 µm. (D) Quantification of Ras signal in the primary cilium (PC) as compared to the plasma membrane (PM) per cell using data as in (B,C), N = 3, mEGFP-K-Ras, n = 31; mEGFP-K-Ras-SI, n = 31. Means ± SD are plotted. Statistical analysis was done with the Mann-Whitney test. (E) Confocal imaging-based quantification of ciliation of C2C12 transfected with the indicated mEGFP-tagged K-Ras constructs and cultured for 72 h in low serum. The mCherry-PDE6D construct was co-expressed at 1:1 DNA ratio with K-Ras variant constructs as indicated, N = 3, n ≥ 200 per condition. Means ± SD are plotted. Statistical analysis was done with one-way ANOVA and Dunnett’s T3 multiple comparisons test. (F) Flow cytometric quantification of MyHC terminal differentiation marker expression in C2C12 cells grown in low serum for 72 h after transfection with mEGFP-tagged K-Ras variant constructs alone or co-transfected with mCherry-PDE6D as in (E), N = 3. Means ± SD are plotted. Statistical analysis was done with one-way ANOVA and Dunnett’s T3 multiple comparisons test.

Journal: bioRxiv

Article Title: K-Ras controls asymmetric cell divisions from the primary cilium

doi: 10.64898/2026.03.05.709789

Figure Lengend Snippet: (A) BRET titration curve of Rluc8-PDE6D and GFP2-K-Ras-SI as compared to GFP2-K-Ras expressed in HEK cells, N = 3. Means ± SD are plotted. Statistical analysis was performed with the extra sum-of-squares F-test. ( B, C ) Confocal images of C2C12 cells grown in low serum for 72 h after transfection with mEGFP-K-Ras (top) or mEGFP-K-Ras-SI (bottom) and immunolabelled for ciliary markers (arrows) Arl13B (B) or acetylated α-tubulin (C). The mCherry-PDE6D construct was co-expressed at 1:1 DNA ratio with K-Ras variant constructs (C). Scale = 10 µm. (D) Quantification of Ras signal in the primary cilium (PC) as compared to the plasma membrane (PM) per cell using data as in (B,C), N = 3, mEGFP-K-Ras, n = 31; mEGFP-K-Ras-SI, n = 31. Means ± SD are plotted. Statistical analysis was done with the Mann-Whitney test. (E) Confocal imaging-based quantification of ciliation of C2C12 transfected with the indicated mEGFP-tagged K-Ras constructs and cultured for 72 h in low serum. The mCherry-PDE6D construct was co-expressed at 1:1 DNA ratio with K-Ras variant constructs as indicated, N = 3, n ≥ 200 per condition. Means ± SD are plotted. Statistical analysis was done with one-way ANOVA and Dunnett’s T3 multiple comparisons test. (F) Flow cytometric quantification of MyHC terminal differentiation marker expression in C2C12 cells grown in low serum for 72 h after transfection with mEGFP-tagged K-Ras variant constructs alone or co-transfected with mCherry-PDE6D as in (E), N = 3. Means ± SD are plotted. Statistical analysis was done with one-way ANOVA and Dunnett’s T3 multiple comparisons test.

Article Snippet: To visualize K-Ras with STED microscopy, C2C12 cells expressing GFP2-K-Ras were fixed with 4 % (w/v) paraformaldehyde and immunolabelled with ChromoTek GFP-booster ATTO647N.

Techniques: Titration, Transfection, Construct, Variant Assay, Clinical Proteomics, Membrane, MANN-WHITNEY, Imaging, Cell Culture, Marker, Expressing